320 Wakara Way Salt Lake City, UT 84108 myriad.com
Myriad Genetic Laboratories's annual revenues are over $500 million (see exact revenue data) and has over 1,000 employees. It is classified as operating in the Medical & Diagnostic Laboratories industry.
What is the company's size? (Annual sales and employees)
What industry is the company in?
Myriad Genetic Laboratories is a publicly traded company on using the ticker symbol MYGN.
Detailed information on company financials and operating reports can be found here:
: MYGN
Myriad Genetic Laboratories Annual Revenue and Growth Rate
Note: Myriad Genetic Laboratories's revenues are gauged from an analysis of company filings.
Investor Activity
Myriad Genetic Laboratories has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
February 12, 2019
1
100%
$0 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Myriad Genetic Laboratories is developing and marketing.
Myriad Genetic Laboratories's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
PRECISE TREATMENT REGISTRY Providing multiple user access to proprietary collections of information relating to clinical data by means of global computer information networks
07/12/2023
PRECISE ONCOLOGY SOLUTIONS Medical testing services for the purpose of testing for biomarkers; genetic and genomic testing related to biomarkers for medical purposes; diagnostic testing in the field of gene sequencing and gene expression profiling for individual cancers, for medical diagnostic and treatment purposes
07/07/2023
PRECISE TUMOR Medical testing services related to oncology; genetic and genomic testing related to oncology
07/07/2023
See all trademarks and details in the Full Report.
Recession Risk
Determine whether Myriad Genetic Laboratories grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Myriad Genetic Laboratories is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Myriad Genetic Laboratories's Largest Competitors
A competitive analysis shows these companies are in the same general field as Myriad Genetic Laboratories, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Myriad Genetic Laboratories.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Myriad Genetic Laboratories and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.